AbbVie drops Caribou partnership on gene-edited CAR-T therapy
AbbVie has terminated its collaboration with Caribou Biosciences to develop two off-the-shelf CAR-T therapies, Caribou disclosed Tuesday afternoon.
AbbVie paid the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.